Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Transparency
Coming Soon to a State or Even City Near You – Part 1 Pricing…
As opposition to and concern about the activities of drug manufacturers continue to mount, increasingly states, and even cities,…
Belgian Sunshine Act Decrees Issued, Providing Guidance
On June 23, 2017, the Belgian “Sunshine Act” became law, requiring life science companies to disclose relationships with…
What California’s New Drug Transparency Law Does – And Doesn’t – Do
We have written numerous times on the transparency bills in various states. California’s Senate Bill 17 is one of those bills that…
California Enacts Legislation on Reporting of Prescription Drug Costs
California’s Senate and Assembly have both passed legislation on publishing prescription drug prices (SB-17) and presented the…
Draft Released on Nevada Pharmaceutical Representative Registration…
Nevada passed legislation earlier this year, putting many new restrictions and regulations on the pharmaceutical industry there.…
Louisiana Price Transparency Measures Go into Effect…With An Interesting…
According to LexisNexis State Net, during 2017, about half of the states and Congress collectively introduced almost 90 measures…
New Report Outlines Steps for Greater Transparency
In July 2017, The Network for Excellence in Health Innovation (NEHI) released a new report that outlines steps for greater…
Chicago Proposes Drug Pricing Transparency Ordinance
Chicago Alderman Edward M. Burke recently held a hearing on the proposed city ordinance, “Chicago Drug Pricing Transparency…
Sunshine Act Takes Effect in South Korea
In early 2017, South Korea joined the global transparency movement and enacted a “Sunshine Act” similar to others found around the…
Canadian Health Minister Considering Forced Transparency
We recently wrote about ten Canadian pharmaceutical companies that are voluntarily disclosing payment amounts to the general…